Estimating Cost-Effectiveness in Type 2 Diabetes

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Medical decision making

• Publication date

  2015-01-16

• Fields of study

  Medicine, Economics

• Identifiers
  DOI 10.1177/0272989X14565821PMID 25596535
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• WITHDRAWN: Metformin monotherapy for type 2 diabetes mellitus.

  2015cited by this paper
• Response to Comment on Khunti et al. Clinical Inertia in People With Type 2 Diabetes: A Retrospective Cohort Study of More Than 80,000 People. Diabetes Care 2013;36:3411–3417

  2014cited by this paper
• Assessment of Unmet Clinical Need in Type 2 Diabetic Patients on Conventional Therapy in the UK

  2014cited by this paper
• The impact on utilities of differences in body weight among Canadian patients with type 2 diabetes

  2014cited by this paper
• [Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin].

  2013cited by this paper
• Personalizing guidelines for diabetes management: twilight or dawn of the expert?

  2013cited by this paper
• Clinical Inertia in People With Type 2 Diabetes

  2013cited by this paper
• Computer modeling of diabetes and its complications: a report on the Fifth Mount Hood challenge meeting.

  2013cited by this paper
• Erratum to: Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  2013cited by this paper
• Health‐related quality of life association with weight change in type 2 diabetes mellitus: perception vs. reality

  2013cited by this paper
• External validity of randomized controlled trials of glycaemic control and vascular disease: how representative are participants?

  2013cited by this paper
• Model Parameter Estimation and Uncertainty Analysis

  2012cited by this paper
• Choice of therapy in patients with type 2 diabetes inadequately controlled with metformin and a sulphonylurea: a systematic review and mixed-treatment comparison meta-analysis

  2012cited by this paper
• Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach

  2012cited by this paper
• Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs

  2012cited by this paper
• Assessing the Relationship between Computational Speed and Precision

  2012cited by this paper
• What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review.

  2012cited by this paper
• Hypoglycaemia: current management and controversies

  2011cited by this paper
• Second-line therapy in patients with type 2 diabetes inadequately controlled with metformin monotherapy: a systematic review and mixed-treatment comparison meta-analysis

  2011cited by this paper
• Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin

  2011cited by this paper
• Weight and glycaemic control in type 2 diabetes: what is the outcome of insulin initiation?

  2011cited by this paper
• Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death

  2011cited by this paper
• Diabetes mellitus, fasting glucose, and risk of cause-specific death.

  2011cited by this paper
• Relationship of baseline HbA1c, HbA1c change and HbA1c target of < 7% with insulin analogues in type 2 diabetes: a meta‐analysis of randomised controlled trials

  2011cited by this paper
• Estimation of primary care treatment costs and treatment efficacy for people with Type 1 and Type 2 diabetes in the United Kingdom from 1997 to 2007 *

  2010cited by this paper
• Estimated costs of acute hospital care for people with diabetes in the United Kingdom: a routine record linkage study in a large region *

  2010cited by this paper
• Understanding the inter‐relationship between improved glycaemic control, hypoglycaemia and weight change within a long‐term economic model

  2010cited by this paper
• A population model evaluating the costs and benefits associated with different oral treatment strategies in people with type 2 diabetes

  2010cited by this paper
• Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

  2010cited by this paper
• Patient‐reported outcomes in a survey of patients treated with oral antihyperglycaemic medications: associations with hypoglycaemia and weight gain

  2009cited by this paper
• Relationship of baseline HbA1c and efficacy of current glucose‐lowering therapies: a meta‐analysis of randomized clinical trials

  2009cited by this paper
• Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis.

  2008cited by this paper
• Computer Modeling of Diabetes and Its Complications

  2007cited by this paper
• Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes

  2006cited by this paper
• Evaluation of the costs and outcomes from changes in risk factors in type 2 diabetes using the Cardiff stochastic simulation cost-utility model (DiabForecaster)

  2006cited by this paper
• The routine collation of health outcomes data from hospital treated subjects in the Health Outcomes Data Repository (HODaR): descriptive analysis from the first 20,000 subjects.

  2005cited by this paper
• Modelling EuroQol health-related utility values for diabetic complications from CODE-2 data.

  2005cited by this paper
• Metformin monotherapy for type 2 diabetes mellitus.

  2005cited by this paper
• A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68)

  2004cited by this paper
• The impact of diabetes‐related complications on healthcare costs: results from the United Kingdom Prospective Diabetes Study (UKPDS Study No. 65)

  2003cited by this paper
• Estimating Utility Values for Health States of Type 2 Diabetic Patients Using the EQ-5D (UKPDS 62)

  2002cited by this paper
• Evaluation of suspected urinary tract infection in ambulatory women: a cost-utility analysis of office-based strategies.

  1998cited by this paper

• Baseline HbA1c and dementia risk at SGLT2i initiation in type 2 diabetes

  2025cites this paper
• A single framework of precision surveillance of diabetes disease prognosis for better care with collaboration

  2022cites this paper
• Health Utilities in Patients with Type 2 Diabetes in Taiwan

  2021cites this paper
• Adoption of and adherence to the Hellenic Diabetes Association guidelines for the management of subjects with type 2 diabetes mellitus by Greek physicians

  2020cites this paper
• A systematic review of economic evaluations in non-insulin antidiabetic treatments for patients with type 2 diabetes mellitus

  2019cites this paper
• TREATMENT OPTIMIZATION FOR PATIENTS WITH TYPE 2 DIABETES

  2018cites this paper
• Dental caries prevention in children and adolescents: a systematic quality assessment of clinical practice guidelines

  2018cites this paper
• Pharmacoeconomic meta-analysis of oral dual therapy options in overweight patients with uncontrolled diabetes

  2017cites this paper
• Individualized Glycemic Control for U.S. Adults With Type 2 Diabetes

  2017cites this paper
• An alternative approach to modelling HbA1c trajectories in patients with type 2 diabetes mellitus

  2017cites this paper
• Managing glycaemia in older people with type 2 diabetes: A retrospective, primary care‐based cohort study, with economic assessment of patient outcomes

  2017cites this paper
• NICE draft type 2 diabetes guidelines: a cause for concern.

  2015cites this paper
• Validation of the UKPDS 82 risk equations within the Cardiff Diabetes Model

  2015cites this paper